Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 208

The DOI matches its Crossref record.

Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin

Frothingham, Richard · 2001 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Abstract

Study Objective. To compare the rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin administration. Design. Retrospective database analysis. Intervention. Evaluation of reported rates of torsades de pointes in patients who received these quinolones between January 1, 1996, and May 2, 2001. Measurements and Main Results. In the United States, 25 cases of torsades de pointes associated with these quinolones (ciprofloxacin 2, ofloxacin 2, levofloxacin 13, gatifloxacin 8, moxifloxacin 0) were identified. Ciprofloxacin was associated with a significantly lower rate of torsades de pointes (0.3 cases/10 million prescriptions, 95% confidence interval [CI] 0.0–1.1) than levofloxacin (5.4/10 million, 95% CI 2.9–9.3, p<0.001) or gatifloxacin (27/10 million, 95% CI 12–53, p<0.001 for comparison with ciprofloxacin or levofloxacin). When the analysis was limited to the first 16 months after initial U.S. approval of the agent, the rates for levofloxacin (16/10 million) and gatifloxacin (27/10 million) were similar (p>0.5). Conclusion. Levofloxacin should be administered with caution in patients with risk factors for QT prolongation. Gatifloxacin should be avoided in the same patient population, and the recommended dosage of 400 mg/day should not be exceeded.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.21.20.1468.34482

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 12

  1. 10.1007/s002280050714 · DOI · Paper page
  2. 10.1592/phco.21.3.301.34206 · DOI
  3. Iannini PB, 2001, Risk of torsades de pointes with non‐cardiac drugs [letter], Br Med J, 322, 46
  4. 10.1592/phco.21.3.261.34200 · doi:10.1592/phco.21.3.261.34200
  5. 10.1592/phco.21.3.358.34205 · doi:10.1592/phco.21.3.358.34205
  6. 10.2165/00002018-199921050-00005 · DOI · Paper page
  7. 10.1093/jac/45.5.557 · doi:10.1093/jac/45.5.557
  8. Food and Drug Administration., 2000, Approved drug products with therapeutic equivalence evaluations, 20th ed
  9. Bayer Corporation., 2000, Cipro (ciprofloxacin) package insert
  10. Ortho‐McNeil Pharmaceutical., 2000, Levaquin (levofloxacin) package insert
  11. Bristol‐Myers Squibb Company., 2001, Tequin (gatifloxacin) package insert
  12. Bayer Corporation., 2001, Avelox (moxifloxacin) package insert

Cited by

See all 208

Metadata

Authors
Frothingham, R.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2001-12
Volume
21
Issue
12
Pages
1468-1472
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2048169841
Cited by
208
References
0
FWCI
10.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin. https://app.cochat.ai/papers/10.1592/phco.21.20.1468.34482
The paper
Frothingham, R. (2001). Rates of Torsades de Pointes Associated with Ciprofloxacin, Ofloxacin, Levofloxacin, Gatifloxacin, and Moxifloxacin. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.21.20.1468.34482

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.